Funder: Crohn's and Colitis Foundation

Due Dates: March 2, 2026 (Year Two Renewal) | May 5, 2026 (LOI, Fall cycle) | June 2, 2026 (Pre-Application) | July 20, 2026 (Full Proposal, Fall) | November 16, 2026 (LOI, Spring cycle) | February 11, 2027 (Full Proposal, Spring) | July 23, 2027 (Full Proposal by invitation)

Funding Amounts: Up to $130,000/year (clinical studies) or $110,000/year (lab-based); max 2 years; total up to $260,000 including 10% indirect costs.

Summary: Supports innovative, clinically relevant research projects aimed at advancing the diagnosis, treatment, and understanding of inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis.

Key Information: Open to investigators worldwide at non-profit institutions; requires faculty appointment for PI; two-stage application (LOI/Pre-Application then Full Proposal).